Characterization of a multidisciplinary team’s role in hospital discharge for patients receiving hypomethylating agents with venetoclax as induction therapy for acute myeloid leukemia
2023; Springer Science+Business Media; Volume: 31; Issue: 4 Linguagem: Inglês
10.1007/s00520-023-07664-z
ISSN1433-7339
AutoresVera Pervitsky, Julie Guglielmo, Benjamin Moskoff, Roxie Kneen, Carol Leija, Deborah Sawicky, Margaret Li Krackeler, Brian A. Jonas, Ryan J. Beechinor,
Tópico(s)Chronic Myeloid Leukemia Treatments
Referência(s)